Caracterização de marcadores inflamatórios associados a pacientes com lúpus eritematoso sistêmico em tratamento

SLE patients receiving standard treatment presented with elevated systemic levels of IL‐6 and IL‐10, reduced neutrophil phagocytic capacity, and reduced lymphocyte expression of CD11b even when symptoms were in remission. These alterations to innate immune components may put these individuals at a greater risk for acquiring infections.